ARCHIVES

Are Cancer Drugs Getting Better? FDA’s Richard Pazdur Says “Yes”

This article is from The Cancer Letter archive.

Vol. 40 No. 07 | February 14, 2014

Download PDF Visit The Full Archive

Related Articles

Firm Begins Phase II Trial Of LDP-341 For Myeloma.

March 30, 2001

J&J, Amgen Settle Lawsuit Over ESAs As FDA Prepares Another Label Change.

July 18, 2008

Clinical Trials Approved By NCI

March 26, 2004

Glaxo, Mass General Begin Phase III Trial Of Tykerb

December 29, 2006

No Cancer Letter For Two Weeks

August 10, 1990

NCI Charging Use Fee for Compounds In Repository

August 12, 1983